Global Neuroendovascular Coil Market Growth 2026-2032

Product Code: 1769279

Industry: Medical Devices & Consumables

Published: Aug 26,2026

Pages: 135

Delivery Time: 2-3 business days

Global Neuroendovascular Coil Market Growth 2026-2032

Product Code: 1769279

Industry: Medical Devices & Consumables

Published: Aug 26,2026

Pages: 135

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Neuroendovascular Coil market size is predicted to grow from US$ 1343 million in 2025 to US$ 1837 million in 2032; it is expected to grow at a CAGR of 4.6% from 2026 to 2032.

Neuroendovascular Coil refers to an implantable neurointerventional device delivered through a microcatheter into an intracranial aneurysm or other eligible neurovascular lesion, where it is deployed and controllably detached to promote mechanical packing, blood-flow reduction, thrombosis, and durable occlusion. The product is typically manufactured from radiopaque and biocompatible platinum or platinum-alloy materials and is supplied as a sterile single-use coil integrated with a delivery and detachment structure. Commercial products are differentiated by treatment role, including framing, filling, finishing, and multi-stage coils; by technology, including bare-metal and hydrogel-modified designs; and by secondary geometry, softness, detachment mechanism, primary coil diameter, expanded diameter, and coil length. The principal clinical application is endovascular embolization of intracranial aneurysms, while selected products are also indicated for other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The market focuses on coils specifically commercialized for neuroendovascular embolization and their integral delivery components.

Key Findings
Intracranial aneurysm embolization remains the principal clinical demand base for Neuroendovascular Coil
Bare-metal coils remain the mainstream technology, while hydrogel-modified coils provide a differentiated high-value product segment
Product competition increasingly centers on conformability, softness, packing efficiency, deliverability, and controlled detachment performance
The competitive structure combines established multinational neurointerventional platforms with increasingly capable Asian manufacturers
Market Trends
Neuroendovascular Coil development is shifting from basic mechanical occlusion toward more refined control of aneurysm framing, filling density, wall apposition, finishing performance, and procedural predictability. Manufacturers are expanding complex three-dimensional geometries, softer distal structures, broader diameter and length matrices, and designs optimized for increasingly low-profile microcatheters. Product portfolios are also becoming more procedure-specific, with dedicated framing, filling, finishing, and multi-stage coils enabling physicians to select different mechanical characteristics during a single intervention. Bare platinum and platinum-alloy coils continue to form the core of commercial portfolios, while hydrogel-modified technologies provide an alternative approach to increasing effective packing volume. Mechanical and electrically controlled detachment systems coexist, with development focused on faster, more predictable release and reduced catheter movement. Over the longer term, coil innovation is increasingly integrated with adjunctive stents, balloons, microcatheters, flow-diversion platforms, and other aneurysm-treatment technologies, reinforcing the importance of complete neurointerventional portfolios rather than individual coil products alone.

Market Dynamics
Drivers
Demand for Neuroendovascular Coil is supported by the established role of endovascular embolization in intracranial aneurysm management, broader availability of neurointerventional treatment, improved cerebrovascular imaging and diagnosis, and continued expansion of specialized stroke and neurovascular centers. The consumable nature of the product creates recurring procedural demand, while individual aneurysm procedures may require multiple coils with different sizes, shapes, and softness levels. Expansion of neurointerventional capabilities in emerging healthcare systems and broader physician familiarity with coil-based techniques further support underlying demand.

Restraints
Market expansion is constrained by pricing pressure from hospital procurement systems, reimbursement controls, centralized purchasing, and increasing competition among clinically comparable coil portfolios. Alternative aneurysm-treatment technologies, particularly flow diverters and intrasaccular flow-disruption devices, are changing treatment selection for certain aneurysm anatomies and can reduce the addressable coil requirement in selected procedures. High regulatory requirements for implantable neurovascular devices, clinical validation costs, quality-control requirements, and the need to maintain extensive inventories across numerous coil specifications also raise operating costs and market-entry barriers.

Opportunities
Growth opportunities are concentrated in differentiated coils that improve conformability, packing efficiency, softness, microcatheter compatibility, and procedural control, as well as in markets where neurointerventional penetration remains below mature-market levels. Hydrogel-modified coils, advanced complex-shape coils, ultra-soft finishing products, and optimized mechanical detachment systems provide opportunities for premium product positioning. Additional potential comes from integrated aneurysm-treatment portfolios combining coils with microcatheters, coil-assist stents, balloons, and access devices, enabling manufacturers to deepen hospital relationships and capture a larger share of procedural expenditure. Local manufacturing and broader regulatory approvals also create opportunities for Asian manufacturers to expand beyond domestic markets.

Challenges
The principal long-term challenge is maintaining meaningful product differentiation in a market where established coil technologies are clinically mature and competing systems increasingly offer broad specification coverage. Manufacturers must demonstrate consistent deployment behavior, detachment reliability, radiopacity, softness, and packing performance while maintaining high manufacturing yields across very small precision components. Physician preference and procedural experience create significant switching barriers, while hospital inventory requirements make comprehensive SKU coverage important for commercial adoption. At the same time, manufacturers must respond to evolving treatment algorithms in which coils may be used alone, with adjunctive devices, or replaced by alternative aneurysm-treatment technologies depending on anatomy and clinical strategy.

Industry Chain Analysis
The upstream Neuroendovascular Coil supply chain centers on implant-grade platinum and platinum-alloy wire, specialty stainless-steel and polymer components, hydrogel or other functional materials for modified coils, precision delivery components, detachment elements, sterile packaging materials, and contract sterilization services. Midstream manufacturing requires micro-wire processing, precision winding, secondary-shape forming, heat setting, joining, delivery-system assembly, detachment-system integration, inspection, cleanroom assembly, packaging, and sterilization. Product value is created primarily through coil geometry design, material engineering, precision manufacturing consistency, detachment reliability, clinical validation, regulatory approval, and the ability to supply a comprehensive specification matrix rather than through raw-material value alone. Downstream distribution extends through direct manufacturer sales and authorized distribution channels to hospitals, stroke centers, neurointerventional centers, and specialist physicians. Profitability therefore depends on product mix, manufacturing yield, regulatory access, hospital penetration, physician adoption, channel structure, procurement pricing, and the ability to generate recurring sales across a broad coil portfolio.

Segment Insights
By technology, bare-metal coils remain the principal commercial category because of their established clinical use, broad specification coverage, and availability across nearly all major manufacturers, while hydrogel-modified coils form a smaller differentiated segment focused on increasing effective filling volume. By treatment role, the market is structured around framing, filling, finishing, and multi-stage products, reflecting the sequential mechanical requirements of aneurysm packing. Three-dimensional complex coils are particularly important for stable framing and spatial distribution, while helical and softer structures are widely used for filling and finishing. Standard, soft, and extra-soft products provide additional differentiation according to support and conformability. Electrical and mechanical detachment represent the two principal release technologies. Specification competition extends across primary coil diameter, expanded diameter, and coil length, making portfolio breadth an important commercial advantage because hospitals require multiple configurations to address diverse aneurysm morphology.

Downstream Market Opportunities
Intracranial aneurysm treatment represents the central downstream opportunity for Neuroendovascular Coil, particularly in hospitals and neurovascular centers with established endovascular treatment capabilities. Demand is increasingly shaped by the need to manage small, irregular, wide-neck, recurrent, and anatomically complex aneurysms using customized combinations of framing, filling, and finishing coils, sometimes together with adjunctive stents or balloons. Broader neurointerventional infrastructure in emerging markets creates additional procedure-volume potential, while mature markets provide opportunities for premium technologies that improve packing efficiency, deliverability, and procedural predictability. Selected products also address other neurovascular embolization procedures, including arteriovenous malformations and arteriovenous fistulae, although intracranial aneurysm embolization remains the dominant application.

Regional Insights
North America and Europe remain mature, high-value Neuroendovascular Coil markets characterized by extensive neurointerventional infrastructure, established physician adoption, broad availability of premium coil portfolios, and strong participation by multinational manufacturers. Japan is distinguished by a sophisticated neuroendovascular clinical base and the presence of domestic manufacturers alongside global suppliers. Asia-Pacific has become a central competitive and expansion arena, driven by rising procedural capability, broader product registration, and the increasing commercial scale of Chinese neurointerventional manufacturers. China combines substantial procedure demand with centralized procurement and strong domestic competition, creating greater pricing pressure while accelerating local product adoption. India and Southeast Asia offer longer-term expansion opportunities as neurointerventional treatment capacity develops, whereas market access in Latin America, the Middle East, and Africa remains more dependent on distributor networks, regulatory registration, and concentration of advanced procedures in major medical centers.

Competitive Landscape Analysis
The Neuroendovascular Coil market combines global neurointerventional platforms with a growing group of Asian manufacturers. Stryker, Medtronic, Johnson & Johnson, Terumo, Penumbra, Balt, Kaneka, and Wallaby Medical compete through established physician relationships, broad coil specification matrices, international regulatory coverage, and complementary aneurysm-treatment portfolios. Genesis MedTech and Meril Life Sciences provide additional Asian participation outside China, while MicroPort NeuroScientific, Peijia Medical, Shanghai HeartCare Medical Technology, Zylox-Tonbridge Medical Technology, Beijing Taijieweiye Technology, Shandong Weigao Interventional Medical Technology, and Hunan Ricoton Technology strengthen competition from China. Competitive differentiation increasingly depends on framing stability, softness, packing efficiency, microcatheter compatibility, detachment reliability, specification breadth, clinical evidence, and access to hospital purchasing channels. Multinational companies retain advantages in global clinical networks and portfolio breadth, while Chinese manufacturers benefit from local regulatory experience, manufacturing economics, domestic hospital coverage, and expanding neurointerventional product portfolios. Competitive intensity is therefore increasingly determined by the ability to combine technical performance with a complete procedural ecosystem, sustainable pricing, and geographic market access.

Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Neuroendovascular Coil Industry Forecast” looks at past sales and reviews total world Neuroendovascular Coil sales in 2025, providing a comprehensive analysis by region and market sector of projected Neuroendovascular Coil sales for 2026 through 2032. With Neuroendovascular Coil sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuroendovascular Coil industry.

This Insight Report provides a comprehensive analysis of the global Neuroendovascular Coil landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuroendovascular Coil portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuroendovascular Coil market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuroendovascular Coil and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuroendovascular Coil.

This report presents a comprehensive overview, market shares, and growth opportunities of Neuroendovascular Coil market by product type, application, key manufacturers and key regions and countries.

Market Segmentation
Segmentation by Type:
    Framing Coils
    Filling Coils
    Finishing Coils
    Multi-Stage Coils

Segmentation by Coil Technology:
    Bare Metal Coils
    Hydrogel-Modified Coils
    Others

Segmentation by Detachment Mechanism:
    Electrical Detachment Coils
    Mechanical Detachment Coils

Segmentation by Application:
    Intracranial Aneurysm Embolization
    Arteriovenous Malformation Embolization
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Stryker Corporation
    Medtronic plc
    Johnson & Johnson
    Terumo Corporation
    Penumbra, Inc.
    Balt Group
    Kaneka Corporation
    Wallaby Medical Holding, Inc.
    Genesis MedTech Group Limited
    Meril Life Sciences Pvt. Ltd.
    MicroPort NeuroScientific Corporation
    Peijia Medical Limited
    Shanghai HeartCare Medical Technology Corporation Limited
    Zylox-Tonbridge Medical Technology Co., Ltd.
    Beijing Taijieweiye Technology Co., Ltd.
    Shandong Weigao Interventional Medical Technology Co., Ltd.
    Hunan Ricoton Technology Development Co., Ltd.

Key Questions Addressed in this Report
What is the 10-year outlook for the global Neuroendovascular Coil market?
What factors are driving Neuroendovascular Coil market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neuroendovascular Coil market opportunities vary by end market size?
How does Neuroendovascular Coil break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Neuroendovascular Coil Annual Sales 2021-2032
        2.1.2 World Current & Future Analysis for Neuroendovascular Coil by Geographic Region, 2021, 2025 & 2032
        2.1.3 World Current & Future Analysis for Neuroendovascular Coil by Country/Region, 2021, 2025 & 2032
    2.2 Neuroendovascular Coil Segment by Type
        2.2.1 Framing Coils
        2.2.2 Filling Coils
        2.2.3 Finishing Coils
        2.2.4 Multi-Stage Coils
        2.2.5 Neuroendovascular Coil Sales by Type
            2.2.5.1 Global Neuroendovascular Coil Sales Market Share by Type (2021-2026)
            2.2.5.2 Global Neuroendovascular Coil Revenue and Market Share by Type (2021-2026)
            2.2.5.3 Global Neuroendovascular Coil Sale Price by Type (2021-2026)
    2.3 Neuroendovascular Coil Segment by Coil Technology
        2.3.1 Bare Metal Coils
        2.3.2 Hydrogel-Modified Coils
        2.3.3 Others
        2.3.4 Neuroendovascular Coil Sales by Coil Technology
            2.3.4.1 Global Neuroendovascular Coil Sales Market Share by Coil Technology (2021-2026)
            2.3.4.2 Global Neuroendovascular Coil Revenue and Market Share by Coil Technology (2021-2026)
            2.3.4.3 Global Neuroendovascular Coil Sale Price by Coil Technology (2021-2026)
    2.4 Neuroendovascular Coil Segment by Detachment Mechanism
        2.4.1 Electrical Detachment Coils
        2.4.2 Mechanical Detachment Coils
        2.4.3 Neuroendovascular Coil Sales by Detachment Mechanism
            2.4.3.1 Global Neuroendovascular Coil Sales Market Share by Detachment Mechanism (2021-2026)
            2.4.3.2 Global Neuroendovascular Coil Revenue and Market Share by Detachment Mechanism (2021-2026)
            2.4.3.3 Global Neuroendovascular Coil Sale Price by Detachment Mechanism (2021-2026)
    2.5 Neuroendovascular Coil Segment by Application
        2.5.1 Intracranial Aneurysm Embolization
        2.5.2 Arteriovenous Malformation Embolization
        2.5.3 Others
        2.5.4 Neuroendovascular Coil Sales by Application
            2.5.4.1 Global Neuroendovascular Coil Sale Market Share by Application (2021-2026)
            2.5.4.2 Global Neuroendovascular Coil Revenue and Market Share by Application (2021-2026)
            2.5.4.3 Global Neuroendovascular Coil Sale Price by Application (2021-2026)

3 Global by Company
    3.1 Global Neuroendovascular Coil Breakdown Data by Company
        3.1.1 Global Neuroendovascular Coil Annual Sales by Company (2021-2026)
        3.1.2 Global Neuroendovascular Coil Sales Market Share by Company (2021-2026)
    3.2 Global Neuroendovascular Coil Annual Revenue by Company (2021-2026)
        3.2.1 Global Neuroendovascular Coil Revenue by Company (2021-2026)
        3.2.2 Global Neuroendovascular Coil Revenue Market Share by Company (2021-2026)
    3.3 Global Neuroendovascular Coil Sale Price by Company
    3.4 Key Manufacturers Neuroendovascular Coil Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Neuroendovascular Coil Product Location Distribution
        3.4.2 Players Neuroendovascular Coil Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Neuroendovascular Coil by Geographic Region
    4.1 World Historic Neuroendovascular Coil Market Size by Geographic Region (2021-2026)
        4.1.1 Global Neuroendovascular Coil Annual Sales by Geographic Region (2021-2026)
        4.1.2 Global Neuroendovascular Coil Annual Revenue by Geographic Region (2021-2026)
    4.2 World Historic Neuroendovascular Coil Market Size by Country/Region (2021-2026)
        4.2.1 Global Neuroendovascular Coil Annual Sales by Country/Region (2021-2026)
        4.2.2 Global Neuroendovascular Coil Annual Revenue by Country/Region (2021-2026)
    4.3 Americas Neuroendovascular Coil Sales Growth
    4.4 APAC Neuroendovascular Coil Sales Growth
    4.5 Europe Neuroendovascular Coil Sales Growth
    4.6 Middle East & Africa Neuroendovascular Coil Sales Growth

5 Americas
    5.1 Americas Neuroendovascular Coil Sales by Country
        5.1.1 Americas Neuroendovascular Coil Sales by Country (2021-2026)
        5.1.2 Americas Neuroendovascular Coil Revenue by Country (2021-2026)
    5.2 Americas Neuroendovascular Coil Sales by Type (2021-2026)
    5.3 Americas Neuroendovascular Coil Sales by Application (2021-2026)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Neuroendovascular Coil Sales by Region
        6.1.1 APAC Neuroendovascular Coil Sales by Region (2021-2026)
        6.1.2 APAC Neuroendovascular Coil Revenue by Region (2021-2026)
    6.2 APAC Neuroendovascular Coil Sales by Type (2021-2026)
    6.3 APAC Neuroendovascular Coil Sales by Application (2021-2026)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Neuroendovascular Coil by Country
        7.1.1 Europe Neuroendovascular Coil Sales by Country (2021-2026)
        7.1.2 Europe Neuroendovascular Coil Revenue by Country (2021-2026)
    7.2 Europe Neuroendovascular Coil Sales by Type (2021-2026)
    7.3 Europe Neuroendovascular Coil Sales by Application (2021-2026)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Neuroendovascular Coil by Country
        8.1.1 Middle East & Africa Neuroendovascular Coil Sales by Country (2021-2026)
        8.1.2 Middle East & Africa Neuroendovascular Coil Revenue by Country (2021-2026)
    8.2 Middle East & Africa Neuroendovascular Coil Sales by Type (2021-2026)
    8.3 Middle East & Africa Neuroendovascular Coil Sales by Application (2021-2026)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Neuroendovascular Coil
    10.3 Manufacturing Process Analysis of Neuroendovascular Coil
    10.4 Industry Chain Structure of Neuroendovascular Coil

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Neuroendovascular Coil Distributors
    11.3 Neuroendovascular Coil Customer

12 World Forecast Review for Neuroendovascular Coil by Geographic Region
    12.1 Global Neuroendovascular Coil Market Size Forecast by Region
        12.1.1 Global Neuroendovascular Coil Forecast by Region (2027-2032)
        12.1.2 Global Neuroendovascular Coil Annual Revenue Forecast by Region (2027-2032)
    12.2 Americas Forecast by Country (2027-2032)
    12.3 APAC Forecast by Region (2027-2032)
    12.4 Europe Forecast by Country (2027-2032)
    12.5 Middle East & Africa Forecast by Country (2027-2032)
    12.6 Global Neuroendovascular Coil Forecast by Type (2027-2032)
    12.7 Global Neuroendovascular Coil Forecast by Application (2027-2032)

13 Key Players Analysis
13.1 Stryker Corporation
13.1.1 Stryker Corporation Company Information
13.1.2 Stryker Corporation Neuroendovascular Coil Product Portfolios and Specifications
13.1.3 Stryker Corporation Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Stryker Corporation Main Business Overview
13.1.5 Stryker Corporation Latest Developments
13.2 Medtronic plc
13.2.1 Medtronic plc Company Information
13.2.2 Medtronic plc Neuroendovascular Coil Product Portfolios and Specifications
13.2.3 Medtronic plc Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic plc Main Business Overview
13.2.5 Medtronic plc Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Neuroendovascular Coil Product Portfolios and Specifications
13.3.3 Johnson & Johnson Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Terumo Corporation
13.4.1 Terumo Corporation Company Information
13.4.2 Terumo Corporation Neuroendovascular Coil Product Portfolios and Specifications
13.4.3 Terumo Corporation Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Terumo Corporation Main Business Overview
13.4.5 Terumo Corporation Latest Developments
13.5 Penumbra, Inc.
13.5.1 Penumbra, Inc. Company Information
13.5.2 Penumbra, Inc. Neuroendovascular Coil Product Portfolios and Specifications
13.5.3 Penumbra, Inc. Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Penumbra, Inc. Main Business Overview
13.5.5 Penumbra, Inc. Latest Developments
13.6 Balt Group
13.6.1 Balt Group Company Information
13.6.2 Balt Group Neuroendovascular Coil Product Portfolios and Specifications
13.6.3 Balt Group Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Balt Group Main Business Overview
13.6.5 Balt Group Latest Developments
13.7 Kaneka Corporation
13.7.1 Kaneka Corporation Company Information
13.7.2 Kaneka Corporation Neuroendovascular Coil Product Portfolios and Specifications
13.7.3 Kaneka Corporation Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Kaneka Corporation Main Business Overview
13.7.5 Kaneka Corporation Latest Developments
13.8 Wallaby Medical Holding, Inc.
13.8.1 Wallaby Medical Holding, Inc. Company Information
13.8.2 Wallaby Medical Holding, Inc. Neuroendovascular Coil Product Portfolios and Specifications
13.8.3 Wallaby Medical Holding, Inc. Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Wallaby Medical Holding, Inc. Main Business Overview
13.8.5 Wallaby Medical Holding, Inc. Latest Developments
13.9 Genesis MedTech Group Limited
13.9.1 Genesis MedTech Group Limited Company Information
13.9.2 Genesis MedTech Group Limited Neuroendovascular Coil Product Portfolios and Specifications
13.9.3 Genesis MedTech Group Limited Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Genesis MedTech Group Limited Main Business Overview
13.9.5 Genesis MedTech Group Limited Latest Developments
13.10 Meril Life Sciences Pvt. Ltd.
13.10.1 Meril Life Sciences Pvt. Ltd. Company Information
13.10.2 Meril Life Sciences Pvt. Ltd. Neuroendovascular Coil Product Portfolios and Specifications
13.10.3 Meril Life Sciences Pvt. Ltd. Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Meril Life Sciences Pvt. Ltd. Main Business Overview
13.10.5 Meril Life Sciences Pvt. Ltd. Latest Developments
13.11 MicroPort NeuroScientific Corporation
13.11.1 MicroPort NeuroScientific Corporation Company Information
13.11.2 MicroPort NeuroScientific Corporation Neuroendovascular Coil Product Portfolios and Specifications
13.11.3 MicroPort NeuroScientific Corporation Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 MicroPort NeuroScientific Corporation Main Business Overview
13.11.5 MicroPort NeuroScientific Corporation Latest Developments
13.12 Peijia Medical Limited
13.12.1 Peijia Medical Limited Company Information
13.12.2 Peijia Medical Limited Neuroendovascular Coil Product Portfolios and Specifications
13.12.3 Peijia Medical Limited Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Peijia Medical Limited Main Business Overview
13.12.5 Peijia Medical Limited Latest Developments
13.13 Shanghai HeartCare Medical Technology Corporation Limited
13.13.1 Shanghai HeartCare Medical Technology Corporation Limited Company Information
13.13.2 Shanghai HeartCare Medical Technology Corporation Limited Neuroendovascular Coil Product Portfolios and Specifications
13.13.3 Shanghai HeartCare Medical Technology Corporation Limited Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shanghai HeartCare Medical Technology Corporation Limited Main Business Overview
13.13.5 Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
13.14 Zylox-Tonbridge Medical Technology Co., Ltd.
13.14.1 Zylox-Tonbridge Medical Technology Co., Ltd. Company Information
13.14.2 Zylox-Tonbridge Medical Technology Co., Ltd. Neuroendovascular Coil Product Portfolios and Specifications
13.14.3 Zylox-Tonbridge Medical Technology Co., Ltd. Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Zylox-Tonbridge Medical Technology Co., Ltd. Main Business Overview
13.14.5 Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
13.15 Beijing Taijieweiye Technology Co., Ltd.
13.15.1 Beijing Taijieweiye Technology Co., Ltd. Company Information
13.15.2 Beijing Taijieweiye Technology Co., Ltd. Neuroendovascular Coil Product Portfolios and Specifications
13.15.3 Beijing Taijieweiye Technology Co., Ltd. Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Beijing Taijieweiye Technology Co., Ltd. Main Business Overview
13.15.5 Beijing Taijieweiye Technology Co., Ltd. Latest Developments
13.16 Shandong Weigao Interventional Medical Technology Co., Ltd.
13.16.1 Shandong Weigao Interventional Medical Technology Co., Ltd. Company Information
13.16.2 Shandong Weigao Interventional Medical Technology Co., Ltd. Neuroendovascular Coil Product Portfolios and Specifications
13.16.3 Shandong Weigao Interventional Medical Technology Co., Ltd. Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Shandong Weigao Interventional Medical Technology Co., Ltd. Main Business Overview
13.16.5 Shandong Weigao Interventional Medical Technology Co., Ltd. Latest Developments
13.17 Hunan Ricoton Technology Development Co., Ltd.
13.17.1 Hunan Ricoton Technology Development Co., Ltd. Company Information
13.17.2 Hunan Ricoton Technology Development Co., Ltd. Neuroendovascular Coil Product Portfolios and Specifications
13.17.3 Hunan Ricoton Technology Development Co., Ltd. Neuroendovascular Coil Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Hunan Ricoton Technology Development Co., Ltd. Main Business Overview
13.17.5 Hunan Ricoton Technology Development Co., Ltd. Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Neuroendovascular Coil Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
 Table 2. Neuroendovascular Coil Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
 Table 3. Major Players of Framing Coils
 Table 4. Major Players of Filling Coils
 Table 5. Major Players of Finishing Coils
 Table 6. Major Players of Multi-Stage Coils
 Table 7. Global Neuroendovascular Coil Sales by Type (2021-2026) & (K Units)
 Table 8. Global Neuroendovascular Coil Sales Market Share by Type (2021-2026)
 Table 9. Global Neuroendovascular Coil Revenue by Type (2021-2026) & ($ million)
 Table 10. Global Neuroendovascular Coil Revenue Market Share by Type (2021-2026)
 Table 11. Global Neuroendovascular Coil Sale Price by Type (2021-2026) & (US$/Unit)
 Table 12. Major Players of Bare Metal Coils
 Table 13. Major Players of Hydrogel-Modified Coils
 Table 14. Major Players of Others
 Table 15. Global Neuroendovascular Coil Sales by Coil Technology (2021-2026) & (K Units)
 Table 16. Global Neuroendovascular Coil Sales Market Share by Coil Technology (2021-2026)
 Table 17. Global Neuroendovascular Coil Revenue by Coil Technology (2021-2026) & ($ million)
 Table 18. Global Neuroendovascular Coil Revenue Market Share by Coil Technology (2021-2026)
 Table 19. Global Neuroendovascular Coil Sale Price by Coil Technology (2021-2026) & (US$/Unit)
 Table 20. Major Players of Electrical Detachment Coils
 Table 21. Major Players of Mechanical Detachment Coils
 Table 22. Global Neuroendovascular Coil Sales by Detachment Mechanism (2021-2026) & (K Units)
 Table 23. Global Neuroendovascular Coil Sales Market Share by Detachment Mechanism (2021-2026)
 Table 24. Global Neuroendovascular Coil Revenue by Detachment Mechanism (2021-2026) & ($ million)
 Table 25. Global Neuroendovascular Coil Revenue Market Share by Detachment Mechanism (2021-2026)
 Table 26. Global Neuroendovascular Coil Sale Price by Detachment Mechanism (2021-2026) & (US$/Unit)
 Table 27. Global Neuroendovascular Coil Sale by Application (2021-2026) & (K Units)
 Table 28. Global Neuroendovascular Coil Sale Market Share by Application (2021-2026)
 Table 29. Global Neuroendovascular Coil Revenue by Application (2021-2026) & ($ million)
 Table 30. Global Neuroendovascular Coil Revenue Market Share by Application (2021-2026)
 Table 31. Global Neuroendovascular Coil Sale Price by Application (2021-2026) & (US$/Unit)
 Table 32. Global Neuroendovascular Coil Sales by Company (2021-2026) & (K Units)
 Table 33. Global Neuroendovascular Coil Sales Market Share by Company (2021-2026)
 Table 34. Global Neuroendovascular Coil Revenue by Company (2021-2026) & ($ millions)
 Table 35. Global Neuroendovascular Coil Revenue Market Share by Company (2021-2026)
 Table 36. Global Neuroendovascular Coil Sale Price by Company (2021-2026) & (US$/Unit)
 Table 37. Key Manufacturers Neuroendovascular Coil Producing Area Distribution and Sales Area
 Table 38. Players Neuroendovascular Coil Products Offered
 Table 39. Neuroendovascular Coil Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
 Table 40. New Products and Potential Entrants
 Table 41. Market M&A Activity & Strategy
 Table 42. Global Neuroendovascular Coil Sales by Geographic Region (2021-2026) & (K Units)
 Table 43. Global Neuroendovascular Coil Sales Market Share Geographic Region (2021-2026)
 Table 44. Global Neuroendovascular Coil Revenue by Geographic Region (2021-2026) & ($ millions)
 Table 45. Global Neuroendovascular Coil Revenue Market Share by Geographic Region (2021-2026)
 Table 46. Global Neuroendovascular Coil Sales by Country/Region (2021-2026) & (K Units)
 Table 47. Global Neuroendovascular Coil Sales Market Share by Country/Region (2021-2026)
 Table 48. Global Neuroendovascular Coil Revenue by Country/Region (2021-2026) & ($ millions)
 Table 49. Global Neuroendovascular Coil Revenue Market Share by Country/Region (2021-2026)
 Table 50. Americas Neuroendovascular Coil Sales by Country (2021-2026) & (K Units)
 Table 51. Americas Neuroendovascular Coil Sales Market Share by Country (2021-2026)
 Table 52. Americas Neuroendovascular Coil Revenue by Country (2021-2026) & ($ millions)
 Table 53. Americas Neuroendovascular Coil Sales by Type (2021-2026) & (K Units)
 Table 54. Americas Neuroendovascular Coil Sales by Application (2021-2026) & (K Units)
 Table 55. APAC Neuroendovascular Coil Sales by Region (2021-2026) & (K Units)
 Table 56. APAC Neuroendovascular Coil Sales Market Share by Region (2021-2026)
 Table 57. APAC Neuroendovascular Coil Revenue by Region (2021-2026) & ($ millions)
 Table 58. APAC Neuroendovascular Coil Sales by Type (2021-2026) & (K Units)
 Table 59. APAC Neuroendovascular Coil Sales by Application (2021-2026) & (K Units)
 Table 60. Europe Neuroendovascular Coil Sales by Country (2021-2026) & (K Units)
 Table 61. Europe Neuroendovascular Coil Revenue by Country (2021-2026) & ($ millions)
 Table 62. Europe Neuroendovascular Coil Sales by Type (2021-2026) & (K Units)
 Table 63. Europe Neuroendovascular Coil Sales by Application (2021-2026) & (K Units)
 Table 64. Middle East & Africa Neuroendovascular Coil Sales by Country (2021-2026) & (K Units)
 Table 65. Middle East & Africa Neuroendovascular Coil Revenue Market Share by Country (2021-2026)
 Table 66. Middle East & Africa Neuroendovascular Coil Sales by Type (2021-2026) & (K Units)
 Table 67. Middle East & Africa Neuroendovascular Coil Sales by Application (2021-2026) & (K Units)
 Table 68. Key Market Drivers & Growth Opportunities of Neuroendovascular Coil
 Table 69. Key Market Challenges & Risks of Neuroendovascular Coil
 Table 70. Key Industry Trends of Neuroendovascular Coil
 Table 71. Neuroendovascular Coil Raw Material
 Table 72. Key Suppliers of Raw Materials
 Table 73. Neuroendovascular Coil Distributors List
 Table 74. Neuroendovascular Coil Customer List
 Table 75. Global Neuroendovascular Coil Sales Forecast by Region (2027-2032) & (K Units)
 Table 76. Global Neuroendovascular Coil Revenue Forecast by Region (2027-2032) & ($ millions)
 Table 77. Americas Neuroendovascular Coil Sales Forecast by Country (2027-2032) & (K Units)
 Table 78. Americas Neuroendovascular Coil Annual Revenue Forecast by Country (2027-2032) & ($ millions)
 Table 79. APAC Neuroendovascular Coil Sales Forecast by Region (2027-2032) & (K Units)
 Table 80. APAC Neuroendovascular Coil Annual Revenue Forecast by Region (2027-2032) & ($ millions)
 Table 81. Europe Neuroendovascular Coil Sales Forecast by Country (2027-2032) & (K Units)
 Table 82. Europe Neuroendovascular Coil Revenue Forecast by Country (2027-2032) & ($ millions)
 Table 83. Middle East & Africa Neuroendovascular Coil Sales Forecast by Country (2027-2032) & (K Units)
 Table 84. Middle East & Africa Neuroendovascular Coil Revenue Forecast by Country (2027-2032) & ($ millions)
 Table 85. Global Neuroendovascular Coil Sales Forecast by Type (2027-2032) & (K Units)
 Table 86. Global Neuroendovascular Coil Revenue Forecast by Type (2027-2032) & ($ millions)
 Table 87. Global Neuroendovascular Coil Sales Forecast by Application (2027-2032) & (K Units)
 Table 88. Global Neuroendovascular Coil Revenue Forecast by Application (2027-2032) & ($ millions)
 Table 89. Stryker Corporation Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 90. Stryker Corporation Neuroendovascular Coil Product Portfolios and Specifications
 Table 91. Stryker Corporation Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 92. Stryker Corporation Main Business
 Table 93. Stryker Corporation Latest Developments
 Table 94. Medtronic plc Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 95. Medtronic plc Neuroendovascular Coil Product Portfolios and Specifications
 Table 96. Medtronic plc Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 97. Medtronic plc Main Business
 Table 98. Medtronic plc Latest Developments
 Table 99. Johnson & Johnson Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 100. Johnson & Johnson Neuroendovascular Coil Product Portfolios and Specifications
 Table 101. Johnson & Johnson Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 102. Johnson & Johnson Main Business
 Table 103. Johnson & Johnson Latest Developments
 Table 104. Terumo Corporation Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 105. Terumo Corporation Neuroendovascular Coil Product Portfolios and Specifications
 Table 106. Terumo Corporation Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 107. Terumo Corporation Main Business
 Table 108. Terumo Corporation Latest Developments
 Table 109. Penumbra, Inc. Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 110. Penumbra, Inc. Neuroendovascular Coil Product Portfolios and Specifications
 Table 111. Penumbra, Inc. Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 112. Penumbra, Inc. Main Business
 Table 113. Penumbra, Inc. Latest Developments
 Table 114. Balt Group Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 115. Balt Group Neuroendovascular Coil Product Portfolios and Specifications
 Table 116. Balt Group Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 117. Balt Group Main Business
 Table 118. Balt Group Latest Developments
 Table 119. Kaneka Corporation Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 120. Kaneka Corporation Neuroendovascular Coil Product Portfolios and Specifications
 Table 121. Kaneka Corporation Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 122. Kaneka Corporation Main Business
 Table 123. Kaneka Corporation Latest Developments
 Table 124. Wallaby Medical Holding, Inc. Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 125. Wallaby Medical Holding, Inc. Neuroendovascular Coil Product Portfolios and Specifications
 Table 126. Wallaby Medical Holding, Inc. Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 127. Wallaby Medical Holding, Inc. Main Business
 Table 128. Wallaby Medical Holding, Inc. Latest Developments
 Table 129. Genesis MedTech Group Limited Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 130. Genesis MedTech Group Limited Neuroendovascular Coil Product Portfolios and Specifications
 Table 131. Genesis MedTech Group Limited Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 132. Genesis MedTech Group Limited Main Business
 Table 133. Genesis MedTech Group Limited Latest Developments
 Table 134. Meril Life Sciences Pvt. Ltd. Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 135. Meril Life Sciences Pvt. Ltd. Neuroendovascular Coil Product Portfolios and Specifications
 Table 136. Meril Life Sciences Pvt. Ltd. Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 137. Meril Life Sciences Pvt. Ltd. Main Business
 Table 138. Meril Life Sciences Pvt. Ltd. Latest Developments
 Table 139. MicroPort NeuroScientific Corporation Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 140. MicroPort NeuroScientific Corporation Neuroendovascular Coil Product Portfolios and Specifications
 Table 141. MicroPort NeuroScientific Corporation Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 142. MicroPort NeuroScientific Corporation Main Business
 Table 143. MicroPort NeuroScientific Corporation Latest Developments
 Table 144. Peijia Medical Limited Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 145. Peijia Medical Limited Neuroendovascular Coil Product Portfolios and Specifications
 Table 146. Peijia Medical Limited Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 147. Peijia Medical Limited Main Business
 Table 148. Peijia Medical Limited Latest Developments
 Table 149. Shanghai HeartCare Medical Technology Corporation Limited Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 150. Shanghai HeartCare Medical Technology Corporation Limited Neuroendovascular Coil Product Portfolios and Specifications
 Table 151. Shanghai HeartCare Medical Technology Corporation Limited Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 152. Shanghai HeartCare Medical Technology Corporation Limited Main Business
 Table 153. Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
 Table 154. Zylox-Tonbridge Medical Technology Co., Ltd. Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 155. Zylox-Tonbridge Medical Technology Co., Ltd. Neuroendovascular Coil Product Portfolios and Specifications
 Table 156. Zylox-Tonbridge Medical Technology Co., Ltd. Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 157. Zylox-Tonbridge Medical Technology Co., Ltd. Main Business
 Table 158. Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
 Table 159. Beijing Taijieweiye Technology Co., Ltd. Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 160. Beijing Taijieweiye Technology Co., Ltd. Neuroendovascular Coil Product Portfolios and Specifications
 Table 161. Beijing Taijieweiye Technology Co., Ltd. Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 162. Beijing Taijieweiye Technology Co., Ltd. Main Business
 Table 163. Beijing Taijieweiye Technology Co., Ltd. Latest Developments
 Table 164. Shandong Weigao Interventional Medical Technology Co., Ltd. Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 165. Shandong Weigao Interventional Medical Technology Co., Ltd. Neuroendovascular Coil Product Portfolios and Specifications
 Table 166. Shandong Weigao Interventional Medical Technology Co., Ltd. Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 167. Shandong Weigao Interventional Medical Technology Co., Ltd. Main Business
 Table 168. Shandong Weigao Interventional Medical Technology Co., Ltd. Latest Developments
 Table 169. Hunan Ricoton Technology Development Co., Ltd. Basic Information, Neuroendovascular Coil Manufacturing Base, Sales Area and Its Competitors
 Table 170. Hunan Ricoton Technology Development Co., Ltd. Neuroendovascular Coil Product Portfolios and Specifications
 Table 171. Hunan Ricoton Technology Development Co., Ltd. Neuroendovascular Coil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 172. Hunan Ricoton Technology Development Co., Ltd. Main Business
 Table 173. Hunan Ricoton Technology Development Co., Ltd. Latest Developments


List of Figures
 Figure 1. Picture of Neuroendovascular Coil
 Figure 2. Neuroendovascular Coil Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Neuroendovascular Coil Sales Growth Rate 2021-2032 (K Units)
 Figure 7. Global Neuroendovascular Coil Revenue Growth Rate 2021-2032 ($ millions)
 Figure 8. Neuroendovascular Coil Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
 Figure 9. Neuroendovascular Coil Sales Market Share by Country/Region (2025)
 Figure 10. Neuroendovascular Coil Sales Market Share by Country/Region (2021, 2025 & 2032)
 Figure 11. Product Picture of Framing Coils
 Figure 12. Product Picture of Filling Coils
 Figure 13. Product Picture of Finishing Coils
 Figure 14. Product Picture of Multi-Stage Coils
 Figure 15. Global Neuroendovascular Coil Sales Market Share by Type in 2026
 Figure 16. Global Neuroendovascular Coil Revenue Market Share by Type (2021-2026)
 Figure 17. Product Picture of Bare Metal Coils
 Figure 18. Product Picture of Hydrogel-Modified Coils
 Figure 19. Product Picture of Others
 Figure 20. Global Neuroendovascular Coil Sales Market Share by Coil Technology in 2026
 Figure 21. Global Neuroendovascular Coil Revenue Market Share by Coil Technology (2021-2026)
 Figure 22. Product Picture of Electrical Detachment Coils
 Figure 23. Product Picture of Mechanical Detachment Coils
 Figure 24. Global Neuroendovascular Coil Sales Market Share by Detachment Mechanism in 2026
 Figure 25. Global Neuroendovascular Coil Revenue Market Share by Detachment Mechanism (2021-2026)
 Figure 26. Neuroendovascular Coil Consumed in Intracranial Aneurysm Embolization
 Figure 27. Global Neuroendovascular Coil Market: Intracranial Aneurysm Embolization (2021-2026) & (K Units)
 Figure 28. Neuroendovascular Coil Consumed in Arteriovenous Malformation Embolization
 Figure 29. Global Neuroendovascular Coil Market: Arteriovenous Malformation Embolization (2021-2026) & (K Units)
 Figure 30. Neuroendovascular Coil Consumed in Others
 Figure 31. Global Neuroendovascular Coil Market: Others (2021-2026) & (K Units)
 Figure 32. Global Neuroendovascular Coil Sale Market Share by Application (2025)
 Figure 33. Global Neuroendovascular Coil Revenue Market Share by Application in 2025
 Figure 34. Neuroendovascular Coil Sales by Company in 2025 (K Units)
 Figure 35. Global Neuroendovascular Coil Sales Market Share by Company in 2025
 Figure 36. Neuroendovascular Coil Revenue by Company in 2025 ($ millions)
 Figure 37. Global Neuroendovascular Coil Revenue Market Share by Company in 2025
 Figure 38. Global Neuroendovascular Coil Sales Market Share by Geographic Region (2021-2026)
 Figure 39. Global Neuroendovascular Coil Revenue Market Share by Geographic Region in 2025
 Figure 40. Americas Neuroendovascular Coil Sales 2021-2026 (K Units)
 Figure 41. Americas Neuroendovascular Coil Revenue 2021-2026 ($ millions)
 Figure 42. APAC Neuroendovascular Coil Sales 2021-2026 (K Units)
 Figure 43. APAC Neuroendovascular Coil Revenue 2021-2026 ($ millions)
 Figure 44. Europe Neuroendovascular Coil Sales 2021-2026 (K Units)
 Figure 45. Europe Neuroendovascular Coil Revenue 2021-2026 ($ millions)
 Figure 46. Middle East & Africa Neuroendovascular Coil Sales 2021-2026 (K Units)
 Figure 47. Middle East & Africa Neuroendovascular Coil Revenue 2021-2026 ($ millions)
 Figure 48. Americas Neuroendovascular Coil Sales Market Share by Country in 2025
 Figure 49. Americas Neuroendovascular Coil Revenue Market Share by Country (2021-2026)
 Figure 50. Americas Neuroendovascular Coil Sales Market Share by Type (2021-2026)
 Figure 51. Americas Neuroendovascular Coil Sales Market Share by Application (2021-2026)
 Figure 52. United States Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 53. Canada Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 54. Mexico Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 55. Brazil Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 56. APAC Neuroendovascular Coil Sales Market Share by Region in 2025
 Figure 57. APAC Neuroendovascular Coil Revenue Market Share by Region (2021-2026)
 Figure 58. APAC Neuroendovascular Coil Sales Market Share by Type (2021-2026)
 Figure 59. APAC Neuroendovascular Coil Sales Market Share by Application (2021-2026)
 Figure 60. China Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 61. Japan Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 62. South Korea Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 63. Southeast Asia Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 64. India Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 65. Australia Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 66. China Taiwan Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 67. Europe Neuroendovascular Coil Sales Market Share by Country in 2025
 Figure 68. Europe Neuroendovascular Coil Revenue Market Share by Country (2021-2026)
 Figure 69. Europe Neuroendovascular Coil Sales Market Share by Type (2021-2026)
 Figure 70. Europe Neuroendovascular Coil Sales Market Share by Application (2021-2026)
 Figure 71. Germany Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 72. France Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 73. UK Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 74. Italy Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 75. Russia Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 76. Middle East & Africa Neuroendovascular Coil Sales Market Share by Country (2021-2026)
 Figure 77. Middle East & Africa Neuroendovascular Coil Sales Market Share by Type (2021-2026)
 Figure 78. Middle East & Africa Neuroendovascular Coil Sales Market Share by Application (2021-2026)
 Figure 79. Egypt Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 80. South Africa Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 81. Israel Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 82. Turkey Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 83. GCC Countries Neuroendovascular Coil Revenue Growth 2021-2026 ($ millions)
 Figure 84. Manufacturing Cost Structure Analysis of Neuroendovascular Coil in 2026
 Figure 85. Manufacturing Process Analysis of Neuroendovascular Coil
 Figure 86. Industry Chain Structure of Neuroendovascular Coil
 Figure 87. Channels of Distribution
 Figure 88. Global Neuroendovascular Coil Sales Market Forecast by Region (2027-2032)
 Figure 89. Global Neuroendovascular Coil Revenue Market Share Forecast by Region (2027-2032)
 Figure 90. Global Neuroendovascular Coil Sales Market Share Forecast by Type (2027-2032)
 Figure 91. Global Neuroendovascular Coil Revenue Market Share Forecast by Type (2027-2032)
 Figure 92. Global Neuroendovascular Coil Sales Market Share Forecast by Application (2027-2032)
 Figure 93. Global Neuroendovascular Coil Revenue Market Share Forecast by Application (2027-2032)

Companies Mentioned

Stryker Corporation

Medtronic plc

Johnson & Johnson

Terumo Corporation

Penumbra, Inc.

Balt Group

Kaneka Corporation

Wallaby Medical Holding, Inc.

Genesis MedTech Group Limited

Meril Life Sciences Pvt. Ltd.

MicroPort NeuroScientific Corporation

Peijia Medical Limited

Shanghai HeartCare Medical Technology Corporation Limited

Zylox-Tonbridge Medical Technology Co., Ltd.

Beijing Taijieweiye Technology Co., Ltd.

Shandong Weigao Interventional Medical Technology Co., Ltd.

Hunan Ricoton Technology Development Co., Ltd.

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff

Paid Databases

Marketing Executives

LPI Internal Repository

Data Analysis

Data Synthesis

Data Validation

Information Gathering

Triangulation with Data Models

Collation of Data

Reference Against Proprietary

Estimation of Key Figures

Databases

Analysis of Derived Insights

Corroboration with Industry Experts

Writing And Finishing Report

Qualitative Analysis

Market drivers

Market size and forecast

Market challenges

Market segmentation

Market trends

Geographical insights

Five forces analysis

Competitive landscape

Frequently Asked Questions

What is the annual compound growth rate of the global Neuroendovascular Coil market size from 2026 to 2032?
The annual compound growth rate of the global Neuroendovascular Coil market is 4.6% 2026 to 2032.
What was the global market size of Neuroendovascular Coil in 2026?
The global market size of Neuroendovascular Coil in 2026 was 1406 US$ M.
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 4.6% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Neuroendovascular Coil in 2032?
The global market size of Neuroendovascular Coil in 2032 was 1837 US$ M.